Maria Kavallaris

15.6k total citations · 6 hit papers
201 papers, 12.3k citations indexed

About

Maria Kavallaris is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Maria Kavallaris has authored 201 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Molecular Biology, 57 papers in Oncology and 52 papers in Cell Biology. Recurrent topics in Maria Kavallaris's work include Microtubule and mitosis dynamics (42 papers), Neuroblastoma Research and Treatments (34 papers) and Nanoparticle-Based Drug Delivery (34 papers). Maria Kavallaris is often cited by papers focused on Microtubule and mitosis dynamics (42 papers), Neuroblastoma Research and Treatments (34 papers) and Nanoparticle-Based Drug Delivery (34 papers). Maria Kavallaris collaborates with scholars based in Australia, United States and Italy. Maria Kavallaris's co-authors include Joshua A. McCarroll, Eddy Pasquier, Michelle Haber, Murray D. Norris, Nicolás André, Susan Band Horwitz, Catherine A. Burkhart, Thomas P. Davis, Amelia L. Parker and Christopher M. Fife and has published in prestigious journals such as Chemical Society Reviews, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Maria Kavallaris

198 papers receiving 12.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microtubules and resistance to tubulin-binding agents

2010 918 citations Maria Kavallaris profile →
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

1997 502 citations Maria Kavallaris, Murray D. Norris et al. profile →
Minimum information reporting in bio–nano experimental literature

2018 482 citations Maria Kavallaris, J. Justin Gooding et al. profile →
Movers and shakers: cell cytoskeleton in cancer metastasis

2014 420 citations Christopher M. Fife, Joshua A. McCarroll et al. British Journal of Pharmacology profile →
Biologically Targeted Magnetic Hyperthermia: Potential and Limitations

2018 382 citations Friederike M. Mansfeld, Maria Kavallaris et al. profile →
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion

2020 280 citations Florida Voli, Emanuele Valli et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Kavallaris Australia	58	6.1k	3.2k	2.4k	2.2k	1.9k	201	12.3k
Edouard C. Nice Australia	74	9.5k 1.6×	4.6k 1.5×	1.1k 0.5×	1.8k 0.8×	1.4k 0.7×	304	17.3k
Lee Jia China	56	5.2k 0.9×	3.4k 1.1×	963 0.4×	1.9k 0.8×	1.0k 0.5×	311	13.2k
Jun Wu China	53	6.8k 1.1×	2.2k 0.7×	677 0.3×	3.9k 1.7×	4.4k 2.3×	244	14.7k
Fuyuhiko Tamanoi United States	68	9.1k 1.5×	1.7k 0.5×	1.9k 0.8×	3.1k 1.4×	3.6k 1.9×	215	16.4k
Crispin R. Dass Australia	54	5.7k 0.9×	1.7k 0.5×	531 0.2×	1.8k 0.8×	2.3k 1.2×	223	11.5k
Daniel B. Longley United Kingdom	42	7.0k 1.1×	4.7k 1.5×	579 0.2×	1.1k 0.5×	999 0.5×	126	12.1k
Min Wu China	59	7.4k 1.2×	1.6k 0.5×	758 0.3×	3.4k 1.5×	817 0.4×	294	14.8k
David A. Boothman United States	67	7.8k 1.3×	3.6k 1.1×	429 0.2×	1.7k 0.8×	1.7k 0.9×	194	13.8k
Bonnie F. Sloane United States	64	6.8k 1.1×	4.3k 1.4×	2.0k 0.8×	1.3k 0.6×	660 0.3×	211	14.5k
Kit S. Lam United States	68	10.8k 1.8×	2.1k 0.7×	589 0.3×	3.7k 1.7×	3.1k 1.6×	404	18.9k

Countries citing papers authored by Maria Kavallaris

Since Specialization

Citations

This map shows the geographic impact of Maria Kavallaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Kavallaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Kavallaris more than expected).

Fields of papers citing papers by Maria Kavallaris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Kavallaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Kavallaris. The network helps show where Maria Kavallaris may publish in the future.

Co-authorship network of co-authors of Maria Kavallaris

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Kavallaris. A scholar is included among the top collaborators of Maria Kavallaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Kavallaris. Maria Kavallaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dolman, M. Emmy M., et al.. (2024). Ex Vivo Modeling of the Tumor Microenvironment to Develop Therapeutic Strategies for Gliomas. Advanced Therapeutics. 7(11). 2 indexed citations

Schofield, Peter, Hannah McCalmont, Ernest Moles, et al.. (2023). An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia. International Journal of Biological Macromolecules. 254(Pt 1). 127596–127596. 4 indexed citations

Du, Eric Y., MoonSun Jung, Joanna N. Skhinas, et al.. (2023). 3D Bioprintable Hydrogel with Tunable Stiffness for Exploring Cells Encapsulated in Matrices of Differing Stiffnesses. ACS Applied Bio Materials. 6(11). 4603–4612. 9 indexed citations

Mariana, Anna, Ernest Moles, Timothy W. Failes, et al.. (2022). Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia. Frontiers in Oncology. 11. 779859–779859. 3 indexed citations

Jung, MoonSun, Joanna N. Skhinas, Eric Y. Du, et al.. (2022). A high-throughput 3D bioprinted cancer cell migration and invasion model with versatile and broad biological applicability. Biomaterials Science. 10(20). 5876–5887. 35 indexed citations

Utama, Robert H., et al.. (2022). Tuning the Mechanical Properties of Multiarm RAFT-Based Block Copolyelectrolyte Hydrogels via Ionic Cross-Linking for 3D Cell Cultures. Biomacromolecules. 24(1). 57–68. 10 indexed citations

Slavich, Eve, et al.. (2022). High temporal resolution RNA-seq time course data reveals widespread synchronous activation between mammalian lncRNAs and neighboring protein-coding genes. Genome Research. 32(8). 1463–1473. 3 indexed citations

Yang, Ying, Friederike M. Mansfeld, Maria Kavallaris, et al.. (2020). Monitoring the heterogeneity in single cell responses to drugs using electrochemical impedance and electrochemical noise. Chemical Science. 12(7). 2558–2566. 7 indexed citations

Voli, Florida, Emanuele Valli, Luigi Lerra, et al.. (2020). Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Research. 80(19). 4129–4144. 280 indexed citations breakdown →

10.

Sadowski, Martin C., Anja Rockstroh, Brian Gabrielli, et al.. (2016). 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells. Molecular Cancer Therapeutics. 16(1). 3–15. 19 indexed citations

11.

Fife, Christopher M., Joshua A. McCarroll, & Maria Kavallaris. (2014). Movers and shakers: cell cytoskeleton in cancer metastasis. British Journal of Pharmacology. 171(24). 5507–5523. 420 indexed citations breakdown →

12.

McCarroll, Joshua A., Pei Pei Gan, Rafael B. Erlich, et al.. (2014). TUBB3 /βIII-Tubulin Acts through the PTEN/AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non–Small Cell Lung Cancer. Cancer Research. 75(2). 415–425. 80 indexed citations

13.

McCarroll, Joshua A., Pei Pei Gan, Marjorie Liu, & Maria Kavallaris. (2010). βIII-Tubulin Is a Multifunctional Protein Involved in Drug Sensitivity and Tumorigenesis in Non–Small Cell Lung Cancer. Cancer Research. 70(12). 4995–5003. 90 indexed citations

14.

Pasquier, Eddy, et al.. (2010). ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties. Molecular Cancer Therapeutics. 9(5). 1408–1418. 41 indexed citations

15.

Gan, Pei Pei, Joshua A. McCarroll, Sela T. Po’uha, et al.. (2010). Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin. Molecular Cancer Therapeutics. 9(5). 1339–1348. 84 indexed citations

16.

Salam, Noeris K., et al.. (2008). Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions. Molecular Cancer Therapeutics. 7(10). 3150–3159. 14 indexed citations

17.

Gan, Pei Pei & Maria Kavallaris. (2008). Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb β-Tubulin in Vinca Alkaloid Sensitivity. Cancer Research. 68(23). 9817–9824. 50 indexed citations

18.

Gan, Pei Pei, Eddy Pasquier, & Maria Kavallaris. (2007). Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer. Cancer Research. 67(19). 9356–9363. 191 indexed citations

19.

Verrills, Nicole M. & Maria Kavallaris. (2003). Drug resistance mechanisms in cancer cells: a proteomics perspective.. PubMed. 5(3). 258–65. 18 indexed citations

20.

Haber, Michelle, Jayne Gilbert, Janice Madafiglio, et al.. (1999). Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells. Oncogene. 18(17). 2777–2782. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact